Gene synthesis is swiftly revolutionizing biomedical research. Gene synthesis services are significantly turning out to be a key part of current biological research processes. Gene synthesis, which is also called DNA synthesis, is the formation of gene-length double-stranded DNA fragments.
This technique is not new. The first gene was synthesized in 1970 as a part of an effort to decrypt a genetic code. Nevertheless, this technology has been accessible as a service from the year 2000. Today, gene synthesis is used to produce plasmids designed in computers, enhance gene expression, and in several other application areas.
Since then, an uncountable number of gene synthesis companies have developed. The global gene synthesis market is perceiving enormous growth mostly owing to the mounting applications of gene synthesis in the healthcare sector. Additionally, in recombinant DNA technology, gene synthesis is extensively accepted tool that comprises recombinant protein production. Moreover, the rising demand for gene synthesis amongst the population with genetic and chronic disorders across the globe and rising investments in the synthetic biology by government organizations and private & public companies are predicted to hasten the global gene synthesis market growth. This is going to pave way for lucrative opportunities for the leading companies functioning in the market in the forthcoming years.
Latest Trends in the Gene Synthesis Market
As per a report by Research Dive, the global gene synthesis market is expected to grow from $11,10,000.0 thousand in 2020 to $42,14,890.1 thousand by 2028. The North America region is the leading user of gene synthesis technique and is expected to take over the major share of the gene synthesis market by garnering a revenue of $16,31,162.5 thousand by 2028.
Moreover, the gene synthesis market in Asia-Pacific is anticipated to grow rapidly with a CAGR of 19.0% from 2021 to 2028. This is mainly owing to the growing rising demand for gene synthesis in this region due to presence of huge population with genetic defects and chronic ailments. Market players are considerably investing in research and development to cater the mounting demand for gene synthesis in research activities. Some of the leading players of the gene synthesis market are Brooks Automation, Inc. (GENEWIZ), Twist Bioscience, Codex DNA, Biomatik, ProMab Biotechnologies, Inc., Boster Biological Technology, Integrated DNA Technologies, Inc., GenScript, OriGene Technologies, Inc., Thermo Fisher Scientific, Inc., and others. These players are concentrated on developing strategies such as mergers and acquisitions, partnerships, novel developments, and collaborations to achieve a prominent position in the global market.
- In June 2019, GenScript®, the global leader in offering gene synthesis services, introduced a substantial upgrade to its GenBrick™ Gene Synthesis platform, bringing scientists access to DNA sequences up to 200kb long with 100% precision.
- In November 2021, OriCiro Genomics, a forerunner in cell-free synthesis and strengthening of genome-scale large DNA for advanced therapeutics and synthetic biology, launched an innovative enzymatic DNA synthesis tool for frequently used vectors.
- In November 2021, Codex DNA, Inc., a synthetic biology company focused on the development of automation solutions for DNA, RNA, and protein synthesis, announced the commercial availability of automated mRNA synthesis kit with integrated capping technology for BioXp™ system.
COVID-19 Impact on the Gene Synthesis Market
The abrupt rise of the coronavirus pandemic in 2020 has positively impacted the global gene synthesis market. This is mainly due to the rising usage of gene synthesis in scientific research activities. For instance, in 2020, the National Institute of Standards and Technology (NIST), unveiled that they have formed artificial gene fragments from the COVID-19 virus. The use of gene synthesis in such developments is greatly contributing to the market growth. Moreover, as the worldwide economy is recovering with the relaxation of pandemic, the use of gene synthesis in medical research projects is gaining traction. This is likely to boom the gene synthesis market in the imminent years.